1 BTC
=
- USD
Simulations Plus, Inc.
As of May 30, 2026 at 24:05 UTC
Chart
About Simulations Plus, Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Market Statistics
Trading Metrics
How to Buy SLP
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy SLP
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesThe biosimulation market is experiencing robust growth, projected to expand from USD 4.7 billion in 2025 to USD 20 billion by 2034 at a CAGR of ~17%. Growth is driven by increasing adoption of model-informed drug development (MIDD), rising complexity of modern therapeutics, regulatory support from FDA and EMA, and the shift toward virtual clinical trials and precision medicine. North America leads the market with 44.24% share, while Asia-Pacific emerges as a major growth contributor.
Certara announced the sale of its Regulatory and Medical Writing business to Veristat for up to $135 million. The divestiture is expected to close in Q2 2026 and will allow the company to focus on its Model-Informed Drug Development platform. Analysts view this as strategically positive timing, with William Blair noting it removes an overhang and provides capital for reinvestment in core biosimulation platforms.
U.S. stock futures fell on Friday amid Middle East tensions over Iran-Israel ceasefire violations and ahead of March CPI data release. Major indices traded lower with the Dow, S&P 500, and Nasdaq 100 all declining slightly. Crude oil surged 2.31% to $100.13/barrel due to geopolitical concerns. Key gainers included Taiwan Semiconductor (up 1.81% on strong Q1 revenue), Simulations Plus (up 13.24% on better-than-expected results), and Urban-gro (up 12.31% on new strategy). Analysts remain cautiously optimistic about 2026 earnings growth despite headwinds from energy shocks and inflation.
The Rosen Law Firm is investigating potential securities claims against Simulations Plus, Inc. (NASDAQ: SLP) for allegedly issuing materially misleading business information. The company missed earnings expectations in Q3 2025, reporting $20.4 million in sales versus a consensus estimate of $20.9 million, causing the stock to plummet 25.75% on July 15, 2025. The firm is preparing a class action lawsuit to recover investor losses.
The Rosen Law Firm is investigating potential securities claims against Simulations Plus, Inc. (NASDAQ: SLP) for allegedly issuing materially misleading business information. The company missed earnings expectations in Q3 2025, reporting $20.4 million in sales versus a consensus estimate of $20.9 million, causing the stock to plummet 25.75% on July 15, 2025. Investors who suffered losses are encouraged to join a prospective class action lawsuit.